Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nir Peled

Showing results (11-20 of 219) with videos related to

Pageof 22
Sort By:
Harefuah|September 26, 2012
[Ectopic pregnancy as a presenting symptom for lung cancer]Shani Attia, Alon Ben-Nun, Tatiana Rabin, et al.
Harefuah|April 28, 2007
[Azithromycin as a novel treatment for bronchiolitis obliterans syndrome]Nir Peled, David Shitrit, Daniele Bendayan, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 5, 2006
Right upper lobe 'window' in right main bronchus stentingNir Peled, David Shitrit, Daniele Bendayan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 26, 2009
Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticlesOrna Barash, Nir Peled, Fred R Hirsch, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Sublingual Flumazenil for the Residual Effects of Hypnotics: Zolpidem and BrotizolamNeriel Katz, Giora Pillar, Eli Peled, et al.
Sleep Medicine|November 1, 2003
DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302 in Jewish hypersomnolent patientsNir Peled, Avraham Amar, Eli Peled, et al.
Journal of Child Neurology|March 2, 2012
Effect of melatonin on seizure frequency in intractable epilepsy: a pilot studyHadassa Goldberg-Stern, Heftsiba Oren, Nir Peled, et al.
Case Reports in Oncology|February 23, 2019
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic MelanomaKeren Rouvinov, Karen Nalbandyan, Victor Kozlov, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancerNir Peled, Koichi Yoshida, Murry W Wynes, et al.
Immunotherapy|July 20, 2010
MAGE A3 antigen-specific cancer immunotherapeuticNir Peled, Ana B Oton, Fred R Hirsch, et al.
Pageof 22

Showing results (11-20 of 219) with videos related to

Sort By:
Pageof 22
Harefuah|September 26, 2012
[Ectopic pregnancy as a presenting symptom for lung cancer]Shani Attia, Alon Ben-Nun, Tatiana Rabin, et al.
Harefuah|April 28, 2007
[Azithromycin as a novel treatment for bronchiolitis obliterans syndrome]Nir Peled, David Shitrit, Daniele Bendayan, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 5, 2006
Right upper lobe 'window' in right main bronchus stentingNir Peled, David Shitrit, Daniele Bendayan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 26, 2009
Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticlesOrna Barash, Nir Peled, Fred R Hirsch, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Sublingual Flumazenil for the Residual Effects of Hypnotics: Zolpidem and BrotizolamNeriel Katz, Giora Pillar, Eli Peled, et al.
Sleep Medicine|November 1, 2003
DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302 in Jewish hypersomnolent patientsNir Peled, Avraham Amar, Eli Peled, et al.
Journal of Child Neurology|March 2, 2012
Effect of melatonin on seizure frequency in intractable epilepsy: a pilot studyHadassa Goldberg-Stern, Heftsiba Oren, Nir Peled, et al.
Case Reports in Oncology|February 23, 2019
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic MelanomaKeren Rouvinov, Karen Nalbandyan, Victor Kozlov, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancerNir Peled, Koichi Yoshida, Murry W Wynes, et al.
Immunotherapy|July 20, 2010
MAGE A3 antigen-specific cancer immunotherapeuticNir Peled, Ana B Oton, Fred R Hirsch, et al.
Pageof 22